Laura Bellio

679 total citations
15 papers, 508 citations indexed

About

Laura Bellio is a scholar working on Hematology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Laura Bellio has authored 15 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 4 papers in Pathology and Forensic Medicine and 4 papers in Immunology. Recurrent topics in Laura Bellio's work include Hematopoietic Stem Cell Transplantation (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and T-cell and B-cell Immunology (3 papers). Laura Bellio is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and T-cell and B-cell Immunology (3 papers). Laura Bellio collaborates with scholars based in Italy, Australia and Germany. Laura Bellio's co-authors include Fabio Ciceri, Sarah Marktel, Jacopo Peccatori, Chiara Bonini, Raffaella Greco, Gianfranco Ferla, Nicoletta Cieri, Carlo Pulitanò, Marcella Arru and Silvano Rossini and has published in prestigious journals such as Blood, Cancer and British journal of surgery.

In The Last Decade

Laura Bellio

14 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Bellio Italy 10 203 186 142 102 82 15 508
Mónica Jiménez Spain 9 130 0.6× 160 0.9× 86 0.6× 204 2.0× 62 0.8× 12 521
Filiz Şen United States 16 117 0.6× 213 1.1× 124 0.9× 278 2.7× 163 2.0× 42 623
J.P. Laporte France 12 272 1.3× 207 1.1× 47 0.3× 171 1.7× 94 1.1× 32 574
Scott Marshall United Kingdom 11 141 0.7× 135 0.7× 161 1.1× 71 0.7× 84 1.0× 32 468
Luděk Raida Czechia 12 142 0.7× 113 0.6× 114 0.8× 125 1.2× 82 1.0× 58 391
Howard R. Terebelo United States 14 473 2.3× 309 1.7× 93 0.7× 61 0.6× 129 1.6× 74 716
Michio Sawada Japan 15 61 0.3× 207 1.1× 152 1.1× 302 3.0× 91 1.1× 37 577
E Vassallo Italy 11 150 0.7× 66 0.4× 91 0.6× 17 0.2× 48 0.6× 26 379
Giuseppe Colucci Italy 12 140 0.7× 179 1.0× 42 0.3× 59 0.6× 93 1.1× 28 548
Annarosa Cuccaro Italy 13 79 0.4× 171 0.9× 55 0.4× 251 2.5× 78 1.0× 35 511

Countries citing papers authored by Laura Bellio

Since Specialization
Citations

This map shows the geographic impact of Laura Bellio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Bellio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Bellio more than expected).

Fields of papers citing papers by Laura Bellio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Bellio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Bellio. The network helps show where Laura Bellio may publish in the future.

Co-authorship network of co-authors of Laura Bellio

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Bellio. A scholar is included among the top collaborators of Laura Bellio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Bellio. Laura Bellio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Cafro, Anna Maria, Laura Anna Pezzetti, Laura Bellio, et al.. (2024). Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients.. PubMed. 22(4). 328–337. 5 indexed citations
2.
Crocchiolo, Roberto, Mariateresa Pugliano, Laura Bellio, et al.. (2021). SARS-COV-2 screening in allogeneic hematopoietic stem cell donors: Implications for the evaluation process and eligibility. Hematology Transfusion and Cell Therapy. 44(1). 13–16.
3.
Lidonnici, Maria Rosa, Annamaria Aprile, Giacomo Mandelli, et al.. (2016). Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone. Haematologica. 102(4). e120–e124. 35 indexed citations
4.
Lidonnici, Maria Rosa, Annamaria Aprile, Giacomo Mandelli, et al.. (2016). Human CD34+ Cells from Different Sources Disclose a Specific Stemness Signature. Blood. 128(22). 4709–4709. 2 indexed citations
5.
Cieri, Nicoletta, Raffaella Greco, Lara Crucitti, et al.. (2015). Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells. Biology of Blood and Marrow Transplantation. 21(8). 1506–1514. 88 indexed citations
6.
Gattillo, Salvatore, Sarah Marktel, Lucia Malabarba, et al.. (2015). Plerixafor on demand in ten healthy family donors as a rescue strategy to achieve an adequate graft for stem cell transplantation. Transfusion. 55(8). 1993–2000. 24 indexed citations
7.
Cieri, Nicoletta, Giacomo Oliveira, Raffaella Greco, et al.. (2015). Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation. Blood. 125(18). 2865–2874. 104 indexed citations
8.
Messina, Carlo, Anna Candoni, Matteo Giovanni Carrabba, et al.. (2014). Wilms' Tumor Gene 1 Transcript Levels in Leukapheresis of Peripheral Blood Hematopoietic Cells Predict Relapse Risk in Patients Autografted for Acute Myeloid Leukemia. Biology of Blood and Marrow Transplantation. 20(10). 1586–1591. 26 indexed citations
9.
Benevolo, Giulia, Alessandra Stacchini, Michele Spina, et al.. (2012). Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination. Blood. 120(16). 3222–3228. 64 indexed citations
10.
Pulitanò, Carlo, Marcella Arru, Laura Bellio, et al.. (2007). A risk score for predicting perioperative blood transfusion in liver surgery. British journal of surgery. 94(7). 860–865. 57 indexed citations
11.
Mercalli, Alessia, Valeria Sordi, Mirco Ponzoni, et al.. (2006). Rapamycin Induces a Caspase-Independent Cell Death in Human Monocytes. American Journal of Transplantation. 6(6). 1331–1341. 21 indexed citations
12.
Lazzarino, Mario, Ester Orlandi, Catherine Klersy, et al.. (1998). Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.. PubMed. 82(3). 576–82. 42 indexed citations
13.
Lazzarino, Mario, Ester Orlandi, Catherine Klersy, et al.. (1998). Serum CA 125 is of clinical value in the staging and follow‐up of patients with non‐hodgkin's lymphoma. Cancer. 82(3). 576–582. 5 indexed citations
14.
Lazzarino, Mario, Ester Orlandi, Catherine Klersy, et al.. (1998). Serum CA 125 is of clinical value in the staging and follow-up of patients with non-hodgkin's lymphoma. Cancer. 82(3). 576–582. 27 indexed citations
15.
Corso, Alessandro, G. Pagnucco, Mario Lazzarino, et al.. (1997). Bone marrow T-cell subsets in patients with monoclonal gammopathies: correlation with clinical stage and disease status.. PubMed. 82(1). 43–6. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026